![Yuval Cabilly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yuval Cabilly
Direttore/Membro del Consiglio presso
AYALA PHARMACEUTICALS, INC.
Profilo
Dr. Yuval Cabilly is a Co- Founder and General Partner at Israel Biotech Fund.
He is on the Board of Directors at Ayala Pharmaceuticals, Inc., Biond Biologics Ltd., Pharma Two B Ltd., Ramot at Tel Aviv University Ltd. and Tau Ventures Ltd. Dr. Cabilly was previously employed as a Board Member by Tamarix Pharma Ltd. He received his undergraduate degree from Tel-Aviv University and a doctorate degree from Tel-Aviv University.
Posizioni attive di Yuval Cabilly
| Società | Posizione | Inizio |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 19/10/2023 |
Israel Biotech Fund
 Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Fondatore | 01/12/2014 |
Ramot at Tel Aviv University Ltd.
 Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as technology transfer company | Direttore/Membro del Consiglio | 01/09/2020 |
Pharma Two B Ltd.
 Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders | Direttore/Membro del Consiglio | 01/09/2020 |
Biond Biologics Ltd.
 Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug discovery and development | Direttore/Membro del Consiglio | 01/03/2021 |
Tau Ventures Ltd.
 Tau Ventures Ltd. Investment ManagersFinance TAU Ventures invests in companies located in Israel. The firm focuses on sectors such as the technology sector. It provides financing for pre-seed and seed stage capital requirements with initial investment size ranging up to USD 1 million. It acts as a lead investor and makes follow-on investments. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Yuval Cabilly
| Società | Posizione | Fine |
|---|---|---|
Tamarix Pharma Ltd
 Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Direttore/Membro del Consiglio | - |
Formazione di Yuval Cabilly
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
8
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Ramot at Tel Aviv University Ltd.
Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as technology transfer company | Commercial Services |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharma Two B Ltd.
Pharma Two B Ltd. Pharmaceuticals: MajorHealth Technology Develops combination drugs for neurological disorders | Health Technology |
Israel Biotech Fund
Israel Biotech Fund Investment ManagersFinance Israel Biotech invests in companies located in Israel. The firm targets companies operating in the fields of biotechnology and pharmaceutical sectors. It provides financing for early stage capital requirements. | Finance |
Biond Biologics Ltd.
Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Engages in drug discovery and development | Health Technology |
Tau Ventures Ltd.
Tau Ventures Ltd. Investment ManagersFinance TAU Ventures invests in companies located in Israel. The firm focuses on sectors such as the technology sector. It provides financing for pre-seed and seed stage capital requirements with initial investment size ranging up to USD 1 million. It acts as a lead investor and makes follow-on investments. | Finance |
Tamarix Pharma Ltd
Tamarix Pharma Ltd Pharmaceuticals: MajorHealth Technology Develops a novel small compounds for reducing excessive apoptosis | Health Technology |
Ayala Pharmaceuticals, Inc.
 Ayala Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops cancer therapeutics | Health Technology |
